LIGAND PHARMACEUTICALS INC — Director's Dealing 2017

Oct 17, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2017-10-13

Reporting Person: HIGGINS JOHN L (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-10-13	Common Stock	M	11384	$21.92	Acquired	150555	Direct
2017-10-13	Common Stock	F	1744	$143.04	Disposed	148811	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2017-10-13	Incentive Stock Option (right to buy)	$21.92	M	11384	Disposed	2023-02-15	Common Stock (11384)	Direct

Footnotes

F1: Represents previously-owned shares delivered to the Issuer in payment of the exercise price of the stock options.

F2: Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/15/13.